ArticleTherapeutic advances in neurological disorders2021

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.

Anat Achiron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.